SmartDyeLivery Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

SmartDyeLivery General Information

Description

Developer of nanoparticulate drug delivery systems intended for the cell-type-specific treatment of impaired cellular signal functions. The company's comprehensively patented platform technology allows for a system- or organ-specific modification of central effector functions of specific cells while reducing or avoiding unwanted side effects, enabling the biotechnology industry to protect the body from the undesirable side effects of highly potent active ingredients on the one hand and the cargo from premature degradation on the other.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • Botzstraße 5
  • 07743 Jena
  • Germany
+49 03641 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SmartDyeLivery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 18-Sep-2020 Completed Generating Revenue
2. Early Stage VC 11-Sep-2018 Completed Generating Revenue
1. Seed Round 16-Dec-2015 Completed Startup
To view SmartDyeLivery’s complete valuation and funding history, request access »

SmartDyeLivery Patents

SmartDyeLivery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11344859-B2 Reactor for the preparation of a formulation Active 27-Nov-2019 000000000 00
DE-102019218404-A1 Reactor for the production of a formulation Pending 27-Nov-2019 00000000 0
US-20210154639-A1 Reactor for the preparation of a formulation Active 27-Nov-2019 00000000000
DE-202019004821-U1 Reactor system for the production of a formulation Active 27-Nov-2019 00000000000
CA-3102011-A1 Reactor for the preparation of a formulation Pending 27-Nov-2019 B01J19/0066
To view SmartDyeLivery’s complete patent history, request access »

SmartDyeLivery Executive Team (5)

Name Title Board Seat Contact Info
Marc Lehmann Managing Director & Chief Executive Officer
Anja Träger Ph.D Co-Founder
Michael Bauer Ph.D Co-Founder
Ulrich Schubert Ph.D Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

SmartDyeLivery Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SmartDyeLivery Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Louis Moser Angel (individual) Minority 000 0000 000000 0
Foundation for Technology, Innovation and Research Thuringia Corporation Minority 000 0000 000000 0
bm-t Beteiligungsmanagement Thuringen Venture Capital Minority 000 0000 000000 0
Sparkasse Jena Investment Bank Minority 000 0000 000000 0
To view SmartDyeLivery’s complete investors history, request access »